Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 8/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25683518 | 0.85 | MAPT (0.35) | MAPTRXFP1TP53L3MBTL1ATM | |
| SCHEMBL25683985 | 0.85 | MAPT (0.38) | MAPTRXFP1TP53L3MBTL1ATM | |
| SCHEMBL25684077 | 0.84 | ALKBH5 (0.43) | MAPTRXFP1TP53KDM4EALDH1A1 | |
| SCHEMBL20110473 | 0.84 | GPR3 (0.48) | MAPTRXFP1TP53L3MBTL1ATM | |
| SCHEMBL14797947 | 0.81 | GPR3 (0.45) | MAPTL3MBTL1ATMKDM4EALDH1A1 | |
| SCHEMBL25684081 | 0.80 | ALKBH5 (0.46) | MAPTKDM4EALDH1A1GPR3CNR2 | |
| SCHEMBL13183677 | 0.78 | ALKBH5 (0.50) | MAPTRXFP1TP53L3MBTL1KDM4E | |
| SCHEMBL25683512 | 0.78 | GPR3 (0.37) | MAPTTP53L3MBTL1ATMKDM4E | |
| SCHEMBL25683581 | 0.78 | ALKBH5 (0.36) | MAPTRXFP1L3MBTL1ATMKDM4E | |
| SCHEMBL25684152 | 0.78 | ALKBH5 (0.36) | MAPTRXFP1L3MBTL1ATMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4190791-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | Kyulux, Inc. (JP) | 2023-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | MAPT 1225/4885RXFP1 2290/4885TP53 3892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.